Calliditas Therapeutics
CALT
#5366
Rank
A$1.66 B
Marketcap
$60.76
Share price
-0.10%
Change (1 day)
127.89%
Change (1 year)

Calliditas Therapeutics (CALT) - P/B ratio

P/B ratio as of November 2024 : 109

According to Calliditas Therapeutics's latest financial reports the company has a price-to-book ratio of 7.1922.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Calliditas Therapeutics - P/B ratio (from 2020 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-3123.3279.67%
2022-12-316.145.64%
2021-12-315.816.25%
2020-12-315.47
2019-12-31N/A
2018-12-31N/A
2017-12-31N/A